Samsung Medical Center — Seoul, Gangnam-gu

Public research footprint of Samsung Medical Center, compiled from the ClinicalTrials.gov public registry.

2,925

Registered studies

928

Active

517

Recruiting now

1,345

Completed

268

Stopped or withdrawn

Most-studied conditions

Small Cell Lung Cancer · Non-Small Cell Lung Cancer (NSCLC) · Hormone Receptor Positive HER-2 Negative Breast Cancer · Muscle-invasive Urothelial Carcinoma

Recently updated registry entries

NCT07492641 — BGB-43395 Plus Letrozole Versus CDK4/6i Plus Letrozole for Patients With Advanced or… (Recruiting)
NCT07202884 — A Study of Orforglipron in Female Participants With Stress Urinary Incontinence Who Have… (Recruiting)
NCT06424288 — A Study to Test Whether Vicadrostat in Combination With Empagliflozin Helps People With… (Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at Samsung Medical Center?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 06, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.